Skip to main content
Journal of Patient-Reported Outcomes
Fig. 2 | Journal of Patient-Reported Outcomes

Fig. 2

From: Development and validation of the Methotrexate Experience Questionnaire, a new methotrexate oral treatment adherence tool in rheumatoid arthritis

Fig. 2

Known-groups validity - Mean (standard deviation) MEQ dimension and Total Scores by a) 6-month PDC, b) 12-month PDC, c) clinician rating of adherence and d) disease severity according to RAPID-3 scores. p-value from T-test for between-group comparisons when two groups, from ANOVA when more than two groups, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001

Back to article page